Literature DB >> 17086001

Perinuclear antineutrophil cytoplasmic antibody-associated vasculitis in a patient with Graves' disease treated with methimazole.

Donna Bilu Martin1, April Deng, Anthony Gaspari, Frederick Pearson.   

Abstract

A 15- year-old Caucasian girl presented with a 1-week history of necrotic ulcers on her bilateral lower extremities, associated with fever and malaise. She had had similar ulcerations on and off over the past 3 years. She had a medical history of Graves' disease, diagnosed in 1999, for which she was taking methimazole (MMI). On physical examination, there were multiple necrotic ulcers with elevated, inflamed borders and an overlying eschar on the bilateral distal extremities (Figure 1). There was one hemorrhagic, flaccid bulla on the lateral aspect of the ankle. Her complete blood count, comprehensive metabolic panel, prothrombin time, and international normalized ratio were within normal limits. Histopathology revealed a neutrophilic vasculitis involving small as well as medium-sized blood vessels. The overlying epidermis and upper dermis showed necrosis (Figure 2). Antinuclear antibody (ANA) was positive at 1:160. Perinuclear (p-) antineutrophil cytoplasmic antibody (ANCA) was positive at 1:320. Cytoplasmic ANCA was negative. The patient did not meet any clinical criteria for a diagnosis of lupus erythematosus. Direct immunofluorescence revealed IgM, complement C3, and fibrin in small- and medium-caliber blood vessels in the dermis, consistent with a leukocytoclastic vasculitis of small- and medium-caliber blood vessels (Figure 3). MMI was stopped and the patient was given prednisone, tapered over 5 days. Her thyroid function remained stable, and she did not develop new necrotic ulcers. One month later, the patient developed urticarial lesions on her lower extremities. Histopathology revealed a lymphocytic vascular reaction. No eosinophils or neutrophils were seen. These newer urticarial lesions resolved. The patient underwent debridement of the thick, necrotic ulcerative eschars. To date, her lesions have resolved (Figure 4). An ANA drawn 5 months after withdrawal of MMI was negative, and p-ANCA was 1:67.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17086001     DOI: 10.1111/j.1540-9740.2006.05350.x

Source DB:  PubMed          Journal:  Skinmed        ISSN: 1540-9740


  3 in total

Review 1.  Propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis.

Authors:  Min Chen; Ying Gao; Xiao-Hui Guo; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2012-06-05       Impact factor: 28.314

2.  Antineutrophilic Cytoplasmic Antibody Positive Vasculitis Associated with Methimazole Use.

Authors:  Deep Shikha; Jonathan Harris; Christine Resta; Patricia Park
Journal:  Case Rep Endocrinol       Date:  2015-04-28

3.  Cutaneous leukocytoclastic vasculitis in the presence of methimazole therapy.

Authors:  Carla de Oliveira Ribeiro; Paula Ferrazzi Magrin; Enoí Aparecida Guedes Vilar; Sandra Maria Barbosa Durães; Rogério Ribeiro Estrella
Journal:  An Bras Dermatol       Date:  2013 Mar-Apr       Impact factor: 1.896

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.